The Europe Endoscopy Fluid Management Market would witness market growth of 6.8% CAGR during the forecast period (2022-2028).
Endoscopy allows the doctor to visually examine an organ without making a large incision. A screen in the operating room lets the doctor see what the endoscope is seeing. Endoscopy is generally utilized to aid doctors in determining the cause of any abnormal symptoms that the patient is going through. Endoscopy allows the doctor to cut a small tissue sample that can later be sent to a lab for further testing, known as endoscopy biopsy. Endoscopy allows the medical professional to look inside the body during a surgical procedure, like healing a stomach ulcer or removing tumors or gallstones.
The exact endoscopy procedure depends on the choice of anesthesia and the type of endoscopy. The patient may have a general anesthetic or sedation. After which the endoscope is inserted through a natural opening. The doctor may make a diagnosis and take a tissue sample for laboratory analysis. Alternatively, the medical expert could perform a small surgery simultaneously. For instance, they may remove a stone from a bile duct or place a stent across an obstructing tumor. The endoscope is removed, once the endoscopy is complete.
In UK, the burden of gastrointestinal and liver disease is heavy for the economy, patients, and the National Health Service (NHS), with gastrointestinal illness being the third most common cause of death and the leading cause of cancer death and also the most common cause of hospital admission. There has been a rise in the incidences of most gastrointestinal diseases, which have significant implications for future healthcare requirements. These include hepatitis C infection, chronic and acute pancreatitis, gallstone disease, upper gastrointestinal bleeding, and alcoholic liver. The growing number of gastrointestinal cancer and other gastrointestinal disorders is expected to increase the usage of endoscopy, which will boost the market growth of endoscopy fluid management in the region.
The Germany market dominated the Europe Endoscopy Fluid Management Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $65.8 Million by 2028. The UK market is anticipated to grow at a CAGR of 5.9% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 7.6% during (2022 - 2028).
Based on Application, the market is segmented into Laparoscopy, Hysteroscopy and Others. Based on Product, the market is segmented into System and Accessories. Based on End User, the market is segmented into Hospital, Clinics and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Endoscopy Fluid Management Market will Hit $970 Million by 2028, at a CAGR of 7.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Olympus Corporation, Steris PLC, B. Braun Melsungen AG, Stryker Corporation, Hologic, Inc., ConMed Corporation, Karl Storz SE & Co. KG, Arthrex, Inc., and COMEG Medical Technologies (Acteon Group).
By Application
By Product
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
